Antiandrogens in Prostate Cancer
A Key to Tailored Endocrine Treatment
Seiten
1996
Springer Berlin (Hersteller)
978-3-540-60599-7 (ISBN)
Springer Berlin (Hersteller)
978-3-540-60599-7 (ISBN)
Lese- und Medienproben
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This work discusses such topics as: aspects of the molecular endocrinology of prostatic cancer; pharmacology of cyproterone acetate; clinical aspects of casodex; pharmacodynamics and pharmacokinetics of nilutamide in animal and man; and a review of the clinical studies with nilutamide.
Some aspects of the molecular endocrinology of prostatic cancer; pharmacology of cyproterone acetate - a short review; cyproterone acetate - results of clinical trials and indications for use in human prostate cancer; biological properties of flutamide; combination therapy with flutamide - the therapy of choice from early to advanced stages of prostate cancer; casodex - preclinical studies; clinical aspects of casodex; pharmacodynamics and pharmacokinetics of nilutamide in animal and man; a review of the clinical studies with nilutamide; indications for antiandrogen treatment in prostate cancer.
| Zusatzinfo | 54 figs., 39 tabs. |
|---|---|
| Verlagsort | Berlin |
| Sprache | englisch |
| Gewicht | 755 g |
| Einbandart | gebunden |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
| ISBN-10 | 3-540-60599-1 / 3540605991 |
| ISBN-13 | 978-3-540-60599-7 / 9783540605997 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
